These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2950337)

  • 1. Saccades in Huntington's disease: initiation defects and distractibility.
    Lasker AG; Zee DS; Hain TC; Folstein SE; Singer HS
    Neurology; 1987 Mar; 37(3):364-70. PubMed ID: 2950337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccades in Huntington's disease: slowing and dysmetria.
    Lasker AG; Zee DS; Hain TC; Folstein SE; Singer HS
    Neurology; 1988 Mar; 38(3):427-31. PubMed ID: 2964566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saccades in Huntington's disease: predictive tracking and interaction between release of fixation and initiation of saccades.
    Tian JR; Zee DS; Lasker AG; Folstein SE
    Neurology; 1991 Jun; 41(6):875-81. PubMed ID: 1828547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual attention in Huntington's disease: the effect of cueing on saccade latencies and manual reaction times.
    Tsai TT; Lasker A; Zee DS
    Neuropsychologia; 1995 Dec; 33(12):1617-26. PubMed ID: 8745119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saccadic impairments in Huntington's disease.
    Peltsch A; Hoffman A; Armstrong I; Pari G; Munoz DP
    Exp Brain Res; 2008 Apr; 186(3):457-69. PubMed ID: 18185924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular motor abnormalities in Huntington's disease.
    Lasker AG; Zee DS
    Vision Res; 1997 Dec; 37(24):3639-45. PubMed ID: 9425536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal ocular motor control in Huntington's disease.
    Leigh RJ; Newman SA; Folstein SE; Lasker AG; Jensen BA
    Neurology; 1983 Oct; 33(10):1268-75. PubMed ID: 6225033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cognitive control in pre-manifest Huntington's disease examined using pre-saccadic EEG potentials - a longitudinal study.
    Ness V; Bestgen AK; Saft C; Beste C
    J Huntingtons Dis; 2014; 3(1):33-43. PubMed ID: 25062763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Horizontal and vertical saccadic eye movement abnormalities in Huntington's chorea.
    Bollen E; Reulen JP; Den Heyer JC; Van der Kamp W; Roos RA; Buruma OJ
    J Neurol Sci; 1986 Jun; 74(1):11-22. PubMed ID: 2941523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oculomotor disorders in Huntington's chorea.
    Avanzini G; Girotti F; Caraceni T; Spreafico R
    J Neurol Neurosurg Psychiatry; 1979 Jul; 42(7):581-9. PubMed ID: 158074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccadic trajectory in Huntington's disease.
    Fielding J; Georgiou-Karistianis N; Millist L; Fahey M; White O
    J Int Neuropsychol Soc; 2006 Jul; 12(4):455-64. PubMed ID: 16981597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye-head coordination in moderately affected Huntington's Disease patients: do head movements facilitate gaze shifts?
    Becker W; Jürgens R; Kassubek J; Ecker D; Kramer B; Landwehrmeyer B
    Exp Brain Res; 2009 Jan; 192(1):97-112. PubMed ID: 18807023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease.
    Henderson T; Georgiou-Karistianis N; White O; Millist L; Williams DR; Churchyard A; Fielding J
    Mov Disord; 2011 Aug; 26(10):1893-9. PubMed ID: 21630355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington's disease.
    Turner TH; Goldstein J; Hamilton JM; Jacobson M; Pirogovsky E; Peavy G; Corey-Bloom J
    J Mot Behav; 2011; 43(4):295-302. PubMed ID: 21774606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered control of visual fixation and saccadic eye movements in attention-deficit hyperactivity disorder.
    Munoz DP; Armstrong IT; Hampton KA; Moore KD
    J Neurophysiol; 2003 Jul; 90(1):503-14. PubMed ID: 12672781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypometric primary saccades and increased variability in visually-guided saccades in Huntington's disease.
    Winograd-Gurvich CT; Georgiou-Karistianis N; Evans A; Millist L; Bradshaw JL; Churchyard A; Chiu E; White OB
    Neuropsychologia; 2003; 41(12):1683-92. PubMed ID: 12887992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saccades in presymptomatic and early stages of Huntington disease.
    Blekher T; Johnson SA; Marshall J; White K; Hui S; Weaver M; Gray J; Yee R; Stout JC; Beristain X; Wojcieszek J; Foroud T
    Neurology; 2006 Aug; 67(3):394-9. PubMed ID: 16855205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of eye movement recordings in patients with Huntington's disease and their offspring.
    Beenen N; Büttner U; Lange HW
    Electroencephalogr Clin Neurophysiol; 1986 Feb; 63(2):119-27. PubMed ID: 2417812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voluntary saccade inhibition deficits correlate with extended white-matter cortico-basal atrophy in Huntington's disease.
    Vaca-Palomares I; Coe BC; Brien DC; Campos-Romo A; Munoz DP; Fernandez-Ruiz J
    Neuroimage Clin; 2017; 15():502-512. PubMed ID: 28649493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccadic eye movements in juvenile variant of Huntington disease.
    Grabska N; Rudzińska M; Wójcik-Pędziwiatr M; Michalski M; Sławek J; Szczudlik A
    Neurol Neurochir Pol; 2014; 48(4):236-41. PubMed ID: 25168321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.